A Phase 1, Pilot, Single-Dose, 3-Way Crossover Study to Evaluate the Pharmacokinetic of AC-1204 Versus Caprylic Triglyceride Oil Including the Effect of Food on Ketone Body Production
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2016
At a glance
- Drugs AC 1204 (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Accera
- 26 Oct 2016 Status changed from active, no longer recruiting to completed.
- 01 Jun 2016 Planned End Date changed from 1 Jun 2016 to 1 Sep 2016.
- 25 Apr 2016 New trial record